SGLT2 inhibitors and the cardiac Na+/H+ exchanger-1: the plot thickens

SGLT2 inhibitors and the cardiac Na+/H+ exchanger-1: the plot thickens

Bibliographic Details
Main Authors:	Chung, YJ, Park, KC, Tokar, S, Eykyn, TR, Fuller, W, Pavlovic, D, Swietach, P, Shattock, MJ
Format:	Journal article
Language:	English
Published:	Oxford University Press 2021

Similar Items

Off-target effects of sodium-glucose co-transporter 2 blockers: empagliflozin does not inhibit Na+/H+ exchanger-1 or lower [Na+]i in the heart
by: Chung, YJ, et al.
Published: (2020)

The SGLT2 inhibitor empagliflozin directly increases ketone utilisation in ischaemic hearts independent of substrate supply
by: Dylan Chase, et al.
Published: (2024-11-01)

Excessive trabeculations and prognosis: the plot thickens
by: Petersen, SE, et al.
Published: (2017)

Functional genomics thickens the biological plot.
by: Virginia Gewin
Published: (2005-06-01)

Cholesterol metabolism and colorectal cancer: the plot thickens
by: Paulina Rzasa, et al.
Published: (2024-01-01)

The plot thickens: OTULIN regulation in cell death
by: Todd Douglas, et al.
Published: (2020-07-01)

Direct cardiac effects of SGLT2 inhibitors
by: Sha Chen, et al.
Published: (2022-03-01)

High-density lipoproteins and cardiovascular disease: the plots thicken.
by: Choudhury, R, et al.
Published: (2013)

High-density lipoproteins and cardiovascular disease: The plots thicken
by: Choudhury, R, et al.
Published: (2013)

Phylogeny, evolution and classification of gall wasps: the plot thickens.
by: Fredrik Ronquist, et al.
Published: (2015-01-01)

Planktonic Aggregates as Hotspots for Heterotrophic Diazotrophy: The Plot Thickens
by: Lasse Riemann, et al.
Published: (2022-04-01)

SGLT2 inhibitors and the cardiac rhythm: unraveling the connections
by: Aritra Paul, et al.
Published: (2024-01-01)

Diagnostic pathways for screen-detected prostate cancer: The plot thickens
by: Hamdy, F, et al.
Published: (2017)

When the plot thickens: a rare complication of rheumatoid arthritis
by: Marianne Scheitel, et al.
Published: (2019-03-01)

The plot thickens: Archetypal narrative structure in the melanoma patient journey
by: Klay Lamprell, et al.
Published: (2018-01-01)

Hemolysis-associated hypercoagulability in sickle cell disease: the plot (and blood) thickens!
by: Mark T. Gladwin, et al.
Published: (2008-01-01)

COVID-19-related multisystem inflammatory syndrome in children: The plot thickens!
by: Jasvinder Kaur Kohli, et al.
Published: (2020-01-01)

Targeting high glucose-induced epigenetic modifications at cardiac level: the role of SGLT2 and SGLT2 inhibitors
by: Lucia Scisciola, et al.
Published: (2023-02-01)

When the Plot Thickens: Writing the Textured Children's Novel in an Era of Corporate Taste
by: Noah Weisz
Published: (2024-06-01)

The Myotonic Plot Thickens: Electrical Myotonia in Antimuscle-Specific Kinase Myasthenia Gravis
by: Marcus Magnussen, et al.
Published: (2015-01-01)

The impacts of SGLT2 inhibitors on the mortality of patients with tuberculosis
by: Chung-Shu Lee, et al.
Published: (2025-05-01)

SGLT2 inhibitors attenuate endothelial to mesenchymal transition and cardiac fibroblast activation
by: Kevin Schmidt, et al.
Published: (2024-07-01)

SGLT2 Inhibitors for Nephrologists
by: Mufti Baleegh-ur-Raheem Mahmood, et al.
Published: (2022-06-01)

SGLT2 Inhibitors for Cardioprotection
by: Sulthan Al Rashid, et al.
Published: (2023-07-01)

Pushing and pulling the cardiac sodium/hydrogen exchanger.
by: Vaughan-Jones, R, et al.
Published: (2008)

Sotagliflozin, a dual SGLT1 and SGLT2 inhibitor: In the heart of the problem
by: Natalia G. Vallianou, et al.
Published: (2021-06-01)

The plot must thicken: a call for increased attention to social surprises in scenarios of climate futures
by: Patrick W Keys
Published: (2023-01-01)

The Plot Thickens: Haploid and Triploid-Like Thalli, Hybridization, and Biased Mating Type Ratios in Letharia
by: Sandra Lorena Ament-Velásquez, et al.
Published: (2021-05-01)

The Renal Effects of SGLT2 Inhibitors
by: Hanny Sawaf, et al.
Published: (2022-06-01)

Neuroprotective Effect of SGLT2 Inhibitors
by: Agnieszka Pawlos, et al.
Published: (2021-11-01)

Benefits of SGLT2 inhibitors in arrhythmias
by: Jinghan Gao, et al.
Published: (2022-10-01)

SGLT2 Inhibitor–Induced Sympathoinhibition
by: Lakshini Y. Herat, PhD, et al.
Published: (2020-02-01)

Structural mechanism of SGLT1 inhibitors
by: Yange Niu, et al.
Published: (2022-10-01)

SGLT2 inhibitor dapagliflozin prevents atherosclerotic and cardiac complications in experimental type 1 diabetes.
by: Judit Hodrea, et al.
Published: (2022-01-01)

Electrocardiographic changes associated with SGLT2 inhibitors and non-SGLT2 inhibitors: A multi-center retrospective study
by: Victor Chien-Chia Wu, et al.
Published: (2022-09-01)

Is cancer incidence modified by SGLT2 inhibitors?
by: Lev M. Berstein
Published: (2019-10-01)

SGLT2 inhibitors: Beyond glycemic control
by: Irtiza Hasan, et al.
Published: (2024-03-01)

The Effects of SGLT2 Inhibitors on Lipid Metabolism
by: Zsolt Szekeres, et al.
Published: (2021-02-01)

Antioxidant Roles of SGLT2 Inhibitors in the Kidney
by: Carmen Llorens-Cebrià, et al.
Published: (2022-01-01)

SGLT2 Inhibitors as Potential Anticancer Agents
by: Debasish Basak, et al.
Published: (2023-06-01)